Episode 61

Inside Lab Safety: Navigating Special Pathogen Testing

What happens behind the sealed doors of a biocontainment laboratory when a patient with a suspected special pathogen—like Ebola or Lassa fever—arrives at a hospital? In this episode of Transmission Interrupted, host Jill Morgan is joined by Vicki Herrera, biocontainment laboratory training and education leader at UNMC, and Colleen Kraft, medical and laboratory director of Emory’s Biocontainment Unit. Together, they break down the critical question: what are “basic labs,” and how can frontline healthcare facilities prepare to deliver essential diagnostics safely during a special pathogen event?

Listen in as Jill, Vicki, and Colleen demystify the realities of emergency lab testing, exploring the tension between the rapid results clinicians want and the vital safety measures laboratorians must uphold. They discuss point-of-care devices, the nuances of risk assessments, and the keys to interdepartmental communication that ensure both effective patient care and laboratory safety. Whether you’re a bedside nurse, an ED provider, or a laboratorian, this candid, practical conversation will help you understand how healthcare teams can work together to deliver safe and swift care—even in the face of emerging infectious threats.

Questions or comments for NETEC? Contact us at info@netec.org.

Visit Transmission Interrupted on the web at netec.org/podcast.

Guests

Vicki Herrera, MS

Research Coordinator

University of Nebraska Medical Center

Vicki Hererra is a Research Coordinator at the University of Nebraska Medical Center in the field of infectious diseases and bioaerosols. She has supported the Nebraska Biocontainment Unit for the past 16 years and currently supports both NETEC and the Nebraska Biocontainment Unit Laboratory by providing education and training to laboratory staff. She is also a co-lead of NETEC's Laboratory Working Group.

Colleen S. Kraft, MD, MSc

Professor, Department of Pathology and Laboratory Medicine

Professor, Infectious Diseases, Department of Medicine

Emory University School of Medicine

Colleen S. Kraft, MD, MSc, is a Professor in the Department of Pathology and Laboratory Medicine as well as a Professor in the Department of Medicine Division of Infectious Diseases at Emory University School of Medicine. Dr. Kraft was the Associate Chief Medical Officer of Emory Hospital from 2020-2023 and is currently the Associate Chief Research Informatics Officer for the Woodruff Health Sciences Center. Dr. Kraft served as the President-Elect, President and Past President of the American Society for Microbiology from 2021-2024. Dr. Kraft was one of the infectious disease physicians at Emory Hospital in 2014 to receive and care for patients who had contracted Ebola virus disease and Lassa fever in West Africa. Dr. Kraft is a clinical consultant for the Emory Healthcare Human Factors Lab, and a director in the Healthcare Test Kitchen Lab, both of which were in response to the desire for high reliability after the care of patients with highly contagious infectious diseases.

Host

Jill Morgan, RN

Emory Healthcare, Atlanta, GA

Jill Morgan is a registered nurse and a subject matter expert in personal protective equipment (PPE) for NETEC. For 35 years, Jill has been an emergency department and critical care nurse, and now splits her time between education for NETEC and clinical research, most of it centering around infection prevention and personal protective equipment. She is a member of the Association for Professionals in Infection Control and Epidemiology (APIC), ASTM International, and the Association for the Advancement of Medical Instrumentation (AAMI)

Resources

About NETEC

A Partnership for Preparedness

The National Emerging Special Pathogens Training and Education Center’s mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources.

Our vision is a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents across the United States public health and health care delivery systems.

For more information, visit NETEC on the web.

NETEC Consultation Services

Assess and Advance Your Readiness for Special Pathogens with Free, Expert Consulting.

NETEC offers free virtual and on-site readiness consulting to help health care facilities and EMS agencies prepare for special pathogen events. Our targeted support services are delivered by experts selected and assigned to each inquiry based on the unique needs of your organization. Have a question? Ask a NETEC expert.

For more information, visit NETEC Consulting Services.

Transcript
Announcer:

This episode of Transmission Interrupted was recorded May 26th, 2026

Jill Morgan:

Hello, and welcome to Transmission Interrupted.

Jill Morgan:

My name is Jill Morgan.

Jill Morgan:

I'm a nurse here at Emory University Hospital in Atlanta, Georgia.

Jill Morgan:

For those of you not yet familiar with NETEC, our mission is to set the gold

Jill Morgan:

standard for special pathogen preparedness and response across health systems in

Jill Morgan:

the U.S. with the goals of driving best practices and closing knowledge gaps

Jill Morgan:

and developing innovative resources.

Jill Morgan:

NETEC works alongside and in cooperation with the CDC and is

Jill Morgan:

funded by ASPR, the Administration for Strategic Preparedness and Response.

Jill Morgan:

I am thrilled today to get to talk to two friends of mine, who just happen to

Jill Morgan:

be brilliant women in their own right.

Jill Morgan:

Today we're gonna talk to, Vicki Herrera.

Jill Morgan:

Vicki is the Biocontainment Laboratory Training and Education

Jill Morgan:

leader for UNMC in Omaha, Nebraska.

Jill Morgan:

She's been in clinical labs for more than 20 years.

Jill Morgan:

Colleen Kraft is the medical and laboratory director of Emory's

Jill Morgan:

Biocontainment Unit here in Atlanta.

Jill Morgan:

She's a professor of pathology and laboratory medicine and a professor

Jill Morgan:

of medicine and infectious diseases.

Jill Morgan:

These two brilliant women co-lead NETEC's laboratory workgroup.

Jill Morgan:

I am thrilled to have you guys here, and we're going to try to demystify

Jill Morgan:

what we mean by basic labs and how we can help healthcare facilities at the

Jill Morgan:

front lines get prepared to actually deliver clinical care for a suspect or

Jill Morgan:

confirmed special pathogens patient.

Jill Morgan:

So welcome, and thanks for joining me today, ladies

Vicki Herrera:

Thanks for having us

Colleen Kraft:

Thank you

Jill Morgan:

Absolutely.

Jill Morgan:

Okay.

Jill Morgan:

So, when I think of a patient presenting to an emergency room or, you know,

Jill Morgan:

wherever, even an urgent care, I think about what immediately happens.

Jill Morgan:

And I know that, you know, like in a really efficient, busy emergency

Jill Morgan:

department, many times somebody's like drawing a rainbow and shipping it off

Jill Morgan:

to the lab, and we'll talk why we don't want that to happen in just a minute.

Jill Morgan:

But I think about what clinical care we want to be able to deliver to

Jill Morgan:

somebody who might have the vague symptoms of these presentations.

Jill Morgan:

So, fever and vomiting, fever and cough, fever and nausea, malaise, body

Jill Morgan:

aches, headache, all those things.

Jill Morgan:

And I think, typically we would want to order a CBC and a seven.

Jill Morgan:

That might be the most basic thing we wanna do.

Jill Morgan:

But how do we do that safely for a patient like this?

Jill Morgan:

So, can we start with how you guys define basic labs and maybe a

Jill Morgan:

little bit about how we get there?

Colleen Kraft:

Yeah.

Colleen Kraft:

I think, we may have to clarify a few terms such as a rainbow for this audience,

Colleen Kraft:

but that just means that they draw all the tubes that they usually draw for any

Colleen Kraft:

type of lab, so that when the laboratory needs something or when the provider

Colleen Kraft:

wants to add something on, then they have it already in the clinical laboratory.

Colleen Kraft:

So I think the reason that we can't and we don't necessarily, think about that,

Colleen Kraft:

is that we want to make sure that we can, do all of those laboratories safely.

Colleen Kraft:

I think I want to answer your question in two different ways,

Colleen Kraft:

if that makes sense, Jill.

Colleen Kraft:

One of them is if you are knowingly testing somebody that you have very

Colleen Kraft:

high suspicion that may have Ebola virus disease or something else like

Colleen Kraft:

Lassa fever, you want to make sure you're doing the testing in a very

Colleen Kraft:

controlled environment, and that's what both, Vicki and I, get the

Colleen Kraft:

privilege to do at our institutions.

Colleen Kraft:

And so in that case, you really can only order what we can do in

Colleen Kraft:

the biocontainment environment.

Colleen Kraft:

That might seem a little austere if you think about, all the things that

Colleen Kraft:

the clinical laboratory can actually order and do on a regular basis.

Colleen Kraft:

But in this case, it's really to make sure that we're not missing anything

Colleen Kraft:

that's life-threatening, while at the same time, making sure that we have

Colleen Kraft:

a baseline, or a standard for what's going on with that patient on that day.

Colleen Kraft:

So for instance, I would consider a Complete Blood Count, or a CBC.

Colleen Kraft:

A Basic Metabolic Panel, so that was the Chem-7 that Jill was referring to.

Colleen Kraft:

We can add on a few other things besides that.

Colleen Kraft:

In our laboratory we can do a urinalysis, pregnancy testing, which you know can

Colleen Kraft:

be done on more of a point-of-care, which we're gonna get to what

Colleen Kraft:

that's called, or what that's about.

Colleen Kraft:

And then, I think especially in our patients that are returning from travel,

Colleen Kraft:

we always test for malaria, which we can do by either a molecular test that

Colleen Kraft:

we have in our laboratory, or we can do more of like a lateral flow assay,

Colleen Kraft:

if you want to think about it that way.

Colleen Kraft:

Where we can do like almost a malaria test just by lateral flow.

Colleen Kraft:

So I think those are what I consider our very basic tests.

Colleen Kraft:

Now again, if you have somebody that's now approaching the emergency department

Colleen Kraft:

and you're not quite sure what to do in that setting, and you're worried that

Colleen Kraft:

they may have something like Ebola Virus Disease, like sincerely worried, not just

Colleen Kraft:

superficially worried, the things that we want to think about are probably the same.

Colleen Kraft:

We want to make sure that they don't have something else that's life-threatening.

Colleen Kraft:

So that's usually gonna involve again, CBC to look for severe anemia.

Colleen Kraft:

I think the electrolytes are absolutely critical in these people that have

Colleen Kraft:

vomiting and diarrheal illnesses.

Colleen Kraft:

We think that a lot of deaths that happen in Ebola treatment units

Colleen Kraft:

across the world happen because of electrolyte imbalance, not necessarily

Colleen Kraft:

because of the virus itself.

Colleen Kraft:

And we may wanna do, depending on how sick the individual is, you may have

Colleen Kraft:

the opportunity to also do a blood gas analysis for like a venous blood gas.

Colleen Kraft:

But remember, where you're sending those labs, also makes a big difference.

Colleen Kraft:

If you're not gonna be able to do those labs in your regular laboratory,

Colleen Kraft:

or if you have to do something special around them, I think really

Colleen Kraft:

trying to work with the laboratory leadership to understand what you can.

Colleen Kraft:

And remember, these things should be available twenty-four seven with

Colleen Kraft:

rapid turnaround times in order to help patients not die from things

Colleen Kraft:

that they may be coming here with

Jill Morgan:

It's a great point, and I'm glad you separated what happens in a

Jill Morgan:

biocontainment lab, like you and Vicki are used to, on the regular, but also in an

Jill Morgan:

emergency department or in an urgent care.

Jill Morgan:

And thinking, really making sure that we bring the laboratorians in because

Jill Morgan:

I think this is where, to me, we have a lot of ED providers who are used

Jill Morgan:

to being able to get lots and lots and lots of results very quickly for

Jill Morgan:

a patient, which is great, right?

Jill Morgan:

Helps patient care.

Jill Morgan:

But then we have laboratorians who are like, "Wait a minute, this is not just a

Jill Morgan:

normal specimen you're asking me about. This might be a special pathogens kind

Jill Morgan:

of event. I don't wanna run this on this, or I, we're not prepared to do

Jill Morgan:

this." And so the, disconnect between what providers might think they need or

Jill Morgan:

think they want and what labs can provide is this ongoing sort of gap or tension.

Jill Morgan:

And maybe thinking about, okay, so I can't get everything I want.

Jill Morgan:

It's like Christmas.

Jill Morgan:

I can't get everything I want, but what is the one thing that

Jill Morgan:

would make me really happy?

Jill Morgan:

Well, a CBC and Basic Metabolic Profile, as you said, or basic,

Jill Morgan:

basic metabolic panel profile.

Jill Morgan:

Which one is it?

Colleen Kraft:

It's probably been all of those throughout the time of our lives.

Colleen Kraft:

But

Colleen Kraft:

yes, I think it's a panel,

Jill Morgan:

I think it's, good to make sure you're

Jill Morgan:

opening up those conversations.

Jill Morgan:

So if you're a laboratorian, you need to go talk to ED providers,

Jill Morgan:

and if you're an ED provider, you need to talk to a laboratorian.

Jill Morgan:

If you're in an urgent care, you might need to talk to your techs,

Jill Morgan:

whoever's over your laboratory, to make sure that you have the devices that

Jill Morgan:

would let you look at these things, because we don't want people to suffer

Jill Morgan:

bad consequences from lack of care.

Jill Morgan:

And so I want to pivot that to something I admit complete

Jill Morgan:

ignorance on until recently.

Jill Morgan:

We've been using this term point-of-care.

Jill Morgan:

I know people here that are friends of mine, have been friends of mine

Jill Morgan:

for years, and they're like, " We work in point-of-care lab." But the

Jill Morgan:

only time I saw them as a bedside nurse was when they came up to do

Jill Morgan:

like an update on a glucometer or one of those other things that we

Jill Morgan:

would keep at the patient's bedside.

Jill Morgan:

So that's what I thought point-of-care was, an iStat, a

Jill Morgan:

glucometer, something like that.

Jill Morgan:

But I understand that actually point-of-care means a whole another

Jill Morgan:

thing to those of you in the lab role, which is a much wider and broader group

Jill Morgan:

of devices than I would've expected . So can we talk a little bit about what you

Jill Morgan:

guys mean by point-of-care and what's the difference between a point-of-care

Jill Morgan:

device and what happens in that mystical, magical place we call a core lab?

Vicki Herrera:

Well, you're not wrong, Jill.

Vicki Herrera:

Like point-of-care, it does include iStats and glucometers and things like that.

Vicki Herrera:

Generally, the point-of-care instrumentation is portable, it's smaller,

Vicki Herrera:

it can be done at the bedside or at the point where somebody is getting cared for.

Vicki Herrera:

So that's general terms for point-of-care.

Vicki Herrera:

There are some larger instruments that are still considered point-of-care.

Vicki Herrera:

They're generally easier to use, less requirements with them.

Vicki Herrera:

But, we still utilize those pieces of equipment, but we use them

Vicki Herrera:

in our biocontainment units so that we can really use them away

Vicki Herrera:

from our main core laboratory.

Vicki Herrera:

The core laboratory has some bigger pieces of equipment.

Vicki Herrera:

Depending on the facility that you're at, they can be really quite large.

Vicki Herrera:

And a lot of times the labs are open concept, so you have multiple people

Vicki Herrera:

walking in and out of areas, doing lots of different things in there.

Vicki Herrera:

So we utilize the point-of-care so that we can really put those in

Vicki Herrera:

our biosafety cabinets, keep them more contained, and use them in a

Vicki Herrera:

smaller, more controlled environment.

Jill Morgan:

So if you're in a doctor's office or a urgent care, and they can

Jill Morgan:

turn around like a CBC and a chemistry of some kind, those are probably being done

Jill Morgan:

on some sort of point-of-care device?

Vicki Herrera:

Some of them, yes.

Vicki Herrera:

They're just a smaller device that you can have close to the bedside.

Jill Morgan:

So the two of you, when you're thinking about education that

Jill Morgan:

your workgroup is working on and the things that you prioritize for Level

Jill Morgan:

two, three, four, facilities, can we talk for a minute about like lab safety

Jill Morgan:

and how you go about thinking about a risk analysis or, how labs should think

Jill Morgan:

about whether they can do this or not?

Colleen Kraft:

I would say that we have to be able to do laboratory testing, and

Colleen Kraft:

so it shouldn't be whether or not we can.

Colleen Kraft:

That's not really the answer.

Colleen Kraft:

And I'm only saying that because we've had that scenario happen to us a few

Colleen Kraft:

times, and I'm sure in Vicki's region as well, where the answer is we're not

Colleen Kraft:

gonna test the patient because we're worried about this, rather than we need

Colleen Kraft:

to figure out a way to avoid, or make ourselv as risk-free as we can while

Colleen Kraft:

testing in order to help the patient.

Jill Morgan:

Vicki, so tell us more about what a lab risk assessment looks like.

Vicki Herrera:

Yeah.

Vicki Herrera:

So really what we're looking for, when you're talking special pathogens, is

Vicki Herrera:

looking at things that would expose the personnel to some of these pathogens.

Vicki Herrera:

So you want to look at every aspect of the test that you're doing.

Vicki Herrera:

Are there sharps involved?

Vicki Herrera:

Are there possibly aerosols that are produced?

Vicki Herrera:

Are you centrifuging?

Vicki Herrera:

Those are all, you know, laboratory terms if you're not familiar.

Vicki Herrera:

But just things that may expose the laboratorian to the pathogen and looking

Vicki Herrera:

at these, with a much deeper dive than your normal clinical laboratory testing.

Vicki Herrera:

The special pathogens have a lower infectious dose, and so we really want

Vicki Herrera:

to scrutinize a lot more of things that could possibly expose the laboratorian.

Vicki Herrera:

So, taking a deep dive into that is going to be helpful in determining not

Vicki Herrera:

whether you can do it, but what safe mitigations you can add to doing that

Vicki Herrera:

test in order to be able to do it.

Vicki Herrera:

We don't want you to be scared of doing the labs, but we do want you to make sure

Vicki Herrera:

that you're taking appropriate cautions.

Vicki Herrera:

So that may be doing something in your biosafety cabinet.

Vicki Herrera:

That may be adding extra PPE.

Vicki Herrera:

Adding some engineering controls that can help you safely mitigate doing the test

Vicki Herrera:

on the pieces of equipment that you have.

Vicki Herrera:

And that can look a variety of different ways in a variety of labs.

Vicki Herrera:

We like to say if you've seen one lab, you've seen one lab.

Vicki Herrera:

So every different laboratory can look completely different, and you

Vicki Herrera:

may need to adjust based on what your workflow is, your airflow, and what

Vicki Herrera:

pieces of equipment you're using.

Jill Morgan:

Yeah.

Jill Morgan:

So this is not something that a laboratory needs to do by themselves.

Jill Morgan:

Like, you probably have infection prevention if you're at a hospital,

Jill Morgan:

and you might have somebody else who comes in and I know in many places

Jill Morgan:

there are actually lab safety people.

Jill Morgan:

And, so thinking about walking through those.

Jill Morgan:

Okay.

Jill Morgan:

So what would I do in this circumstance?

Jill Morgan:

I love, Vicki, you mentioning this risk assessment, because I think

Jill Morgan:

both as a clinician, if you're an ED nurse or provider versus a

Jill Morgan:

laboratorian, we both should be using the standard precautions that keep us

Jill Morgan:

safe most of the time we do our jobs.

Jill Morgan:

B ut when we know that there's this heightened risk, right?

Jill Morgan:

Like you said, there's a lower infectious dose, they're scarier, they're whatever,

Jill Morgan:

we really need to think about what steps we can take to ensure our own safety

Jill Morgan:

above and beyond the standard precautions.

Jill Morgan:

At the bedside we might call those transmission-based precautions, and

Jill Morgan:

in the lab you're really talking about what transmission risks do

Jill Morgan:

these devices add to my workflow.

Jill Morgan:

Either way, we want to react with, "This is what I can do to mitigate those

Jill Morgan:

risks," versus, "I'm scared, I don't want to do this." And I'm certainly

Jill Morgan:

not saying that healthcare providers or laboratorians are consciously doing

Jill Morgan:

that, but things do scare us and we hear about these pathogens we do not

Jill Morgan:

know much about them, and suddenly here somebody wants us to handle that blood.

Jill Morgan:

Well, that is kind of intimidating . I mean, I understand people being sort of

Jill Morgan:

anxious about it, but if we do it right, and please tell me I'm right about this.

Jill Morgan:

If we do it right, then we can really minimize any risk that is

Jill Morgan:

presented to a laboratorian or a healthcare provider of any kind.

Vicki Herrera:

Absolutly I agree.

Vicki Herrera:

These sometimes sound really scary, right?

Vicki Herrera:

There's a reason, and we know that laboratory infections

Vicki Herrera:

have occurred before.

Vicki Herrera:

So it is a little bit scary, especially when you hear something

Vicki Herrera:

that may not have a current treatment.

Vicki Herrera:

But yeah, I agree that I cannot state this enough, but communication

Vicki Herrera:

is really key in this situation.

Vicki Herrera:

Notifying your laboratory as soon as you possibly can that this may

Vicki Herrera:

be a possibility, that way they can implement some of their mitigation

Vicki Herrera:

strategies, whether that's PPE, whether that's designating one or

Vicki Herrera:

two people to be in the area at the time, or whatever that mitigation is.

Vicki Herrera:

By communicating early, the laboratory is aware, and they can take extra

Vicki Herrera:

precautions in these situations.

Jill Morgan:

Yeah.

Jill Morgan:

And I think that's one of the things that we try to emphasize to those people who

Jill Morgan:

might be getting these specimens, right?

Jill Morgan:

So, typically in many of these situations we're not calling

Jill Morgan:

phlebotomy in to draw these.

Jill Morgan:

If we have a suspicion, probably the one person we can put in the room who can

Jill Morgan:

get a good history and do a good exam and put in an IV may be the one drawing your

Jill Morgan:

lab specimens or getting that nasal swab.

Jill Morgan:

So I think it's important to say we want everybody to use caution.

Jill Morgan:

We want people to not pass risk downstream, and that means that

Jill Morgan:

a specimen needs to be clean.

Jill Morgan:

Don't send those nasty, covered in blood, specimens to your lab.

Jill Morgan:

That's just not fair.

Jill Morgan:

Especially when you're talking about something that is as

Jill Morgan:

fear-provoking as a special pathogen.

Jill Morgan:

So you mentioned PPE, Vicki, and I want to get back to that because of course it's my

Jill Morgan:

favorite topic . But also, are there some everybody should do this with PPE rules

Jill Morgan:

in the lab and then you just add layers on top depending on what you're working with?

Jill Morgan:

Or are there special things that you think laboratorians should all have in order to

Jill Morgan:

handle specimens from patients like this?

Vicki Herrera:

Well, you probably know better than I do on the PPE.

Vicki Herrera:

You do such a great job with PPE.

Vicki Herrera:

But, definitely with your PPE, you need to practice, right?

Vicki Herrera:

It's not all the same.

Vicki Herrera:

Not everybody has the same PPE, so there's different things you can do.

Vicki Herrera:

We talk a lot about, working in a BSL-2, which most core laboratories

Vicki Herrera:

are a BSL-2, but we talk about using BSL-3 precautions, right?

Vicki Herrera:

So that would be a fluid-impermeable gown, adding that to your list.

Vicki Herrera:

An N95, maybe a face shield, doing something to cover all those mucous

Vicki Herrera:

membranes, maybe double gloves.

Vicki Herrera:

It really kind of depends on your facility.

Vicki Herrera:

That may or may not… actually, BSL-3, you would usually use double gloves.

Vicki Herrera:

Some people use triple gloves.

Vicki Herrera:

That's a whole different story.

Vicki Herrera:

Adding those things, but you need to practice, right?

Vicki Herrera:

You need to be able to get those gloves off safely.

Vicki Herrera:

You need to have a procedure for doffing all of that stuff and

Vicki Herrera:

where you're gonna put it as well.

Vicki Herrera:

So again, practicing all of that.

Vicki Herrera:

But, again, every lab is a little different, and what they have on

Vicki Herrera:

hand may be a little bit different.

Vicki Herrera:

But in general, covering all of your mucous membranes are gonna

Vicki Herrera:

be an important thing here.

Jill Morgan:

And it would seem like a lot of that would depend on whether I

Jill Morgan:

can do what I'm doing with a specimen, like inside a glove box or under a hood.

Jill Morgan:

And PPE etiquette, like just like we know it at the bedside, is super

Jill Morgan:

important . You can't have your hands up under that hood and be dealing with the

Jill Morgan:

specimen and then reach out to get your pen or reach out to get something else.

Jill Morgan:

Like obeying sort of the rules of, once your hands are under there,

Jill Morgan:

we're gonna consider them dirty and we're not gonna touch other

Jill Morgan:

stuff in the lab with those hands

Vicki Herrera:

Yes, if you're gonna use your BSL3 precautions, once

Vicki Herrera:

you're in a biosafety cabinet, everything stays in there, including

Vicki Herrera:

that outer layer of gloves.

Vicki Herrera:

You don't want to bring that out.

Vicki Herrera:

You don't want to touch other things, especially if you opened

Vicki Herrera:

a tube, because that could potentially aerosolize some things.

Vicki Herrera:

You also want to just change your gloves a lot in general.

Vicki Herrera:

If you're touching that specimen, you're moving it, you don't want

Vicki Herrera:

to touch other pieces of equipment.

Vicki Herrera:

So just being very mindful of what you are touching and how often you

Vicki Herrera:

should be changing those gloves.

Vicki Herrera:

Not touching your face.

Vicki Herrera:

Um, you know, everybody wants to adjust their glasses, or they have

Vicki Herrera:

an itch that they need to scratch.

Vicki Herrera:

Being very mindful of that when you have your PPE on and

Vicki Herrera:

not touching anything really.

Vicki Herrera:

Um, which is, you know, easier said than done because people touch their

Vicki Herrera:

face more often than they realize.

Vicki Herrera:

And so really practicing with your PPE and having somebody observe you and

Vicki Herrera:

noticing and, having maybe that partner that's helping you just to say, "Hey,

Vicki Herrera:

wait, don't touch anything." Or maybe, you know, they notice a little splash

Vicki Herrera:

that needs to be cleaned up right away.

Vicki Herrera:

That extra person to observe you can be very helpful as well.

Jill Morgan:

Yeah.

Jill Morgan:

you know, we tell people all the time, like, "Don't touch your face," and, use

Jill Morgan:

a trained observer or someone similar, like you said, a helper or observer

Jill Morgan:

that can hand you something if you need it, rather than having you move

Jill Morgan:

your dirty hands out from under a hood.

Jill Morgan:

And I think about that whole idea of leaving the dirty gloves where they

Jill Morgan:

are because, you don't want to just turn around and here you've been so

Jill Morgan:

worried about these things inside the hood, and then you're just gonna

Jill Morgan:

contaminate the rest of the lab.

Jill Morgan:

That defeats the whole purpose

Jill Morgan:

. Vicki Herrera: Well, just the way the clinical lab is laid out as well.

Jill Morgan:

You know, their processes and their workflow tend to be a little

Jill Morgan:

bit different than when you're dealing with a special pathogen.

Jill Morgan:

So like you may have a biosafety cabinet that already has some of their supplies

Jill Morgan:

in it, and really when you're working with your special pathogen or, the

Jill Morgan:

potential to have that, you want to clean all those supplies out and only

Jill Morgan:

bring in the stuff that is necessary.

Jill Morgan:

So you might need to clear off both your biosafety cabinet and the work area

Jill Morgan:

or, space around the instrument, just to ensure that if there were a splash,

Jill Morgan:

that you're not contaminating extra pieces of material that you don't need.

Jill Morgan:

Yeah.

Jill Morgan:

And if I were manipulating like all the tubes and toppers and things like

Jill Morgan:

that, that you guys have to do, I would think that practicing with two

Jill Morgan:

pair of gloves on is really important.

Jill Morgan:

Because I know how hard it was for me, I mean it sounds dumb, but one

Jill Morgan:

of the most frustrating parts of dealing with Ebola patients was the

Jill Morgan:

very simple act of having two pair of gloves on and not being able to open

Jill Morgan:

a Band-Aid, because you just couldn't feel that tiny little fine wax paper.

Jill Morgan:

Or finding the end of a roll of tape and you think, "Oh my gosh,

Jill Morgan:

this is just gonna drive me crazy."

Jill Morgan:

But I imagine in lab you guys also have all these little tiny fidgety

Jill Morgan:

things you have to pick up that might be hard if you're not used

Jill Morgan:

to doing it in two pair of gloves.

Vicki Herrera:

Yeah, absolutely.

Vicki Herrera:

It's worth practicing in two pairs of gloves just to feel how different

Vicki Herrera:

it is to pipette open tubes, some of those things that you do take for

Vicki Herrera:

granted with the textile sensation.

Jill Morgan:

I know we need to wrap up, and I wanted to just

Jill Morgan:

sort of go through a few points, that you and, Colleen have made.

Jill Morgan:

And I think it's, worth reiterating something you said early on, Vicky,

Jill Morgan:

which was communication is so important . So the only way we're

Jill Morgan:

going to close the gap between what bedside clinicians, care providers want

Jill Morgan:

to deliver, and what laboratorians can and will deliver, is to talk about it.

Jill Morgan:

Gotta talk about what the expectations are.

Jill Morgan:

What the needs are.

Jill Morgan:

How these things will happen.

Jill Morgan:

How can we do it safely?

Jill Morgan:

What's the turnaround time?

Jill Morgan:

Are there other ways to do it, like maybe utilizing an iStat or a VBG machine

Jill Morgan:

that isn't used very often to at least get me a little bit of basic chemistry?

Jill Morgan:

How can you bridge that gap, so that we can deliver good care and not

Jill Morgan:

put anybody unnecessarily at risk?

Jill Morgan:

And then, I think this whole idea of what a point-of-care device is, again, like I

Jill Morgan:

had no idea that a Pochi, or a Piccolo, or a GEM, was a point-of-care device.

Jill Morgan:

I didn't think about them as being point-of-care, and I know

Jill Morgan:

you call them portable, but to me, they're just sitting there.

Jill Morgan:

They're not like an Accu-Chek machine or a glucometer or whatever that

Jill Morgan:

I'm taking in and, probably putting on my patient's bedside table.

Jill Morgan:

So I'm glad to know that all those devices, that could be really

Jill Morgan:

helpful for people, are also just considered point-of-care.

Jill Morgan:

That still means they have rules to follow, right?

Jill Morgan:

I mean, lab is an extremely well-regulated industry.

Jill Morgan:

But it might mean that a point-of-care device is much easier

Jill Morgan:

for somebody to think about using than it is to think about sending

Jill Morgan:

a specimen to their core lab.

Vicki Herrera:

Yeah, absolutely.

Vicki Herrera:

So, I think the important thing to do really is to create a team, some

Vicki Herrera:

leadership in your laboratory, that can discuss things with the providers,

Vicki Herrera:

anybody else that needs to be involved.

Vicki Herrera:

That could be a variety of people, right?

Vicki Herrera:

So creating some sort of a team where you can discuss those things and really

Vicki Herrera:

discussing with the providers, what are the tests that you really, really need?

Vicki Herrera:

Not what you want, but what do you really, really need?

Vicki Herrera:

And then the lab doing a risk assessment on that side, to figure

Vicki Herrera:

out how they can provide that for you.

Vicki Herrera:

And a point-of-care device may or may not be the answer.

Vicki Herrera:

I mean, there's a lot of things that come into play with that, right?

Vicki Herrera:

There's regulatory issues.

Vicki Herrera:

You still have to follow all the regulatory standards.

Vicki Herrera:

There may be a cost issue.

Vicki Herrera:

There may be only one in your ED that you may not be able to

Vicki Herrera:

dedicate to a particular patient that you're investigating.

Vicki Herrera:

There's a variety of reasons.

Vicki Herrera:

So really walking through those, doing the risk assessments, determining is

Vicki Herrera:

this really the safest way we can do it?

Vicki Herrera:

Is this a possibility or do we need to relook at something and do it differently?

Vicki Herrera:

And then communicating that back to your providers, so that they have a clear

Vicki Herrera:

understanding as to why or why not you are able to provide those particular tests.

Vicki Herrera:

Again, you may have to go back to the drawing board, but as long as you can have

Vicki Herrera:

that communication back and forth with your providers as to why it's feasible

Vicki Herrera:

or not feasible for that particular instrumentation and those particular tests

Vicki Herrera:

are going to move the needle a lot faster than just saying yes or no to things.

Jill Morgan:

Yeah.

Jill Morgan:

I thought you were going to break into the Spice Girls song, "Tell me what you

Jill Morgan:

want, what you really, really want." So I think that the other piece that I just

Jill Morgan:

want to get in here, because I have been threatened every time I come up with

Jill Morgan:

what I think is a brilliant idea about lab, I get told I might go to lab jail

Jill Morgan:

because it is such a regulated industry.

Jill Morgan:

But that's of course for the protection of our data, right?

Jill Morgan:

We want to be able to trust lab results and therefore we have to be really

Jill Morgan:

persnickety about who does what and on what devices and how those devices

Jill Morgan:

are validated and all that stuff.

Jill Morgan:

So I don't mean any disrespect to that.

Jill Morgan:

But for somebody who says like, "Oh, our ED doesn't currently use an iStat, but if

Jill Morgan:

we had a potential Ebola patient, we could just use one like from another unit."

Jill Morgan:

Well, no, because those nurses aren't checked off on that device.

Jill Morgan:

We have to make sure all those pieces are in place.

Jill Morgan:

Like it might sound easy to do, but there are some rules about why that can't

Jill Morgan:

just be thrown in at the last minute.

Jill Morgan:

And so your advice to like really talk about this and have a meeting

Jill Morgan:

and have the right people at the table ahead of time is, I think, critical.

Jill Morgan:

Not just for avoiding lab jail, but for making sure we're getting

Jill Morgan:

the results that can be trusted.

Vicki Herrera:

Yeah, a-agree.

Vicki Herrera:

There's a lot of regulatory, things that do go into bringing up a test, and you

Vicki Herrera:

do still have to follow all of that.

Vicki Herrera:

And sometimes it takes a little bit of time to get that, especially if you're

Vicki Herrera:

bringing a new piece of equipment, it does take a little bit of time to bring

Vicki Herrera:

that up and have that test available.

Vicki Herrera:

So those early conversations are really crucial in making sure that

Vicki Herrera:

the providers have the tests that they need to provide adequate care.

Jill Morgan:

All right.

Jill Morgan:

So when we say every healthcare facility should be able to offer a patient

Jill Morgan:

who presents with a suspected or confirmed special pathogens patients,

Jill Morgan:

so we're talking about Ebola, Lassa, Marburg, MERS, all those things.

Jill Morgan:

Basic labs would include, a basic chemistry, so whether you

Jill Morgan:

call it a BMP or a Chem-7, we're talking about some electrolytes.

Jill Morgan:

We wanna know a little bit about their CBC, and maybe we won't

Jill Morgan:

get the whole thing, because I know some of those are available.

Jill Morgan:

Maybe you get a hemoglobin, a hematocrit on an iStat, or you might get a white

Jill Morgan:

count on something, you get the idea.

Jill Morgan:

Parts of a CBC chemistry, maybe a urine pregnancy , if that's

Jill Morgan:

the patient population that you might be taking care of.

Jill Morgan:

A malaria test would be a really value add because so many of these

Jill Morgan:

suspect patients end up with malaria.

Jill Morgan:

And then everything else is really gravy after that point it sounds like.

Jill Morgan:

That if we can get those down, the rest are just like bonus prizes.

Jill Morgan:

Does that sound right?

Vicki Herrera:

Yes, but keep in mind that not every single facility

Vicki Herrera:

may have all those tests available or be able to provide them, right?

Vicki Herrera:

We want them to be able to provide basic stuff, right?

Vicki Herrera:

But that's also where those conversations come into play.

Vicki Herrera:

And if they aren't in a position that they can offer some of those or offer

Vicki Herrera:

what the physicians really need to assess, that is where you phone a friend, right?

Vicki Herrera:

So maybe you have a facility nearby that could offer those tests.

Vicki Herrera:

So that might be a conversation with your partner lab.

Vicki Herrera:

I don't want to say reference lab because we don't want to send stuff to a reference

Vicki Herrera:

lab, but a reference lab could mean different things to different facilities.

Vicki Herrera:

It could just mean their larger laboratory that's associated

Vicki Herrera:

with their facility, right?

Vicki Herrera:

So making sure that you're having those conversations, and if you can

Vicki Herrera:

get something maybe that the larger laboratory is able to provide.

Vicki Herrera:

Again, making sure that you keep all of those safe practices and again,

Vicki Herrera:

having those conversations about what makes sense and what you can

Vicki Herrera:

and cannot do in your laboratory, but still being able to provide the

Vicki Herrera:

testing that they need in some way

Jill Morgan:

Yeah.

Jill Morgan:

And then before you think about what you need to wear or how you need to

Jill Morgan:

do it, you need to think about a risk assessment for what handling these

Jill Morgan:

specimens and doing those tests, that we just mentioned, might entail.

Jill Morgan:

Which equipment you're gonna be using, what risks specifically might

Jill Morgan:

you have, so that you can make sure you're addressing those risks with

Jill Morgan:

your choices of protection mechanisms

Jill Morgan:

. Parts of that are PPE, but parts of that, like Vicki said, would be things

Jill Morgan:

like knowing where your airflow is.

Jill Morgan:

Are you using a hood?

Jill Morgan:

Do you have negative pressure somewhere?

Jill Morgan:

Are you using a glove box?

Jill Morgan:

Because those change what PPE we might really say is super

Jill Morgan:

important to that situation.

Jill Morgan:

So basic labs, risk assessment, and then thinking about the importance of

Jill Morgan:

this communication so you understand everybody's on their same playing field

Jill Morgan:

for how we can advance the medical care these folks desperately need.

Vicki Herrera:

You hit the nail on the head.

Jill Morgan:

Well, thank you guys so much.

Jill Morgan:

to Vicki and Colleen, I know that the NETEC Laboratory Working Group is

Jill Morgan:

in great hands with the two of you.

Jill Morgan:

So thank you.

Jill Morgan:

For those of you listening at home, thank you for tuning in

Jill Morgan:

to this episode on Lab Basics.

Jill Morgan:

We hope you'll join us for future episodes on a wide range of topics.

Jill Morgan:

We've talked about everything from trash to treasure and healthcare worker safety

Jill Morgan:

and personal protective equipment.

Jill Morgan:

So please, think about subscribing to future episodes, which you can do at

Jill Morgan:

If you have questions for NETEC or ideas for future shows, please feel

Jill Morgan:

free to contact us at info@netec.org.

Jill Morgan:

And we appreciate you being here, and we hope we'll see you next

Jill Morgan:

time on Transmission Interrupted.

About the Podcast

Show artwork for Transmission Interrupted
Transmission Interrupted
Presented in cooperation with the CDC and funded by ASPR, the Assistant Secretary for Preparedness and Response. For more information, visit NETEC on the web at www.netec.org.